BG62620B1 - Carbocyclic compounds - Google Patents

Carbocyclic compounds

Info

Publication number
BG62620B1
BG62620B1 BG100699A BG10069996A BG62620B1 BG 62620 B1 BG62620 B1 BG 62620B1 BG 100699 A BG100699 A BG 100699A BG 10069996 A BG10069996 A BG 10069996A BG 62620 B1 BG62620 B1 BG 62620B1
Authority
BG
Bulgaria
Prior art keywords
carbocyclic compounds
carbocyclic
compounds
terahydropyrano
medicine
Prior art date
Application number
BG100699A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG100699A (bg
Inventor
Jose R. Gomez
Jose M. Calderon
Silvestre Garcia-Ochoa Dorado
Maria T. Fraile Gabaldon
Julia C. Pichel
Jose Fiandor Roman
Domingo Garsallo Viola
Juan C. Cueva Zurita
Jose L. Lavandera Diaz
Sophie Huss
Original Assignee
Glaxo Wellcome S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP94500173A external-priority patent/EP0712859A1/en
Priority claimed from EP94500175A external-priority patent/EP0711784A1/en
Application filed by Glaxo Wellcome S.A. filed Critical Glaxo Wellcome S.A.
Publication of BG100699A publication Critical patent/BG100699A/bg
Publication of BG62620B1 publication Critical patent/BG62620B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG100699A 1994-11-08 1996-07-05 Carbocyclic compounds BG62620B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94500173A EP0712859A1 (en) 1994-11-08 1994-11-08 Antifungal Sordarin derivatives
EP94500175A EP0711784A1 (en) 1994-11-08 1994-11-08 Antifungal Sordarin derivatives
PCT/EP1995/004331 WO1996014326A1 (en) 1994-11-08 1995-11-06 Antifungal sordaridin derivatives

Publications (2)

Publication Number Publication Date
BG100699A BG100699A (bg) 1997-02-28
BG62620B1 true BG62620B1 (en) 2000-03-31

Family

ID=26137608

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100699A BG62620B1 (en) 1994-11-08 1996-07-05 Carbocyclic compounds

Country Status (35)

Country Link
US (2) US5854280A (fi)
EP (1) EP0753001B1 (fi)
JP (1) JPH09508144A (fi)
KR (1) KR100391401B1 (fi)
CN (1) CN1056849C (fi)
AP (1) AP614A (fi)
AR (1) AR013815A1 (fi)
AT (1) ATE184284T1 (fi)
AU (1) AU704405B2 (fi)
BG (1) BG62620B1 (fi)
BR (1) BR9506473A (fi)
CA (1) CA2179403A1 (fi)
CO (1) CO4520226A1 (fi)
CZ (1) CZ202796A3 (fi)
DE (1) DE69512041T2 (fi)
DK (1) DK0753001T3 (fi)
EE (1) EE9600117A (fi)
ES (1) ES2137549T3 (fi)
FI (1) FI962773A (fi)
GR (1) GR3031677T3 (fi)
HK (1) HK1004222A1 (fi)
HU (1) HU218611B (fi)
IL (1) IL115905A0 (fi)
IS (1) IS4352A (fi)
MX (1) MX9602563A (fi)
NO (1) NO307092B1 (fi)
NZ (1) NZ296091A (fi)
OA (1) OA10303A (fi)
PE (1) PE49696A1 (fi)
RU (1) RU2152398C1 (fi)
SI (1) SI0753001T1 (fi)
SK (1) SK88496A3 (fi)
TW (1) TW321644B (fi)
WO (1) WO1996014326A1 (fi)
ZA (1) ZA959362B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0901493A1 (en) * 1996-05-08 1999-03-17 Glaxo Wellcome S.A. Process for the preparation of an indacene compound
US6436395B1 (en) * 1996-09-18 2002-08-20 Merck & Co., Inc. Rosellinia subiculata ATCC 74386 and fungus ATCC 74387 for producing sordarin compounds for fungi control
US6040463A (en) * 1996-10-07 2000-03-21 Merck & Co., Inc. Sordarin derivatives
US6096511A (en) * 1997-06-10 2000-08-01 Merck & Co., Inc. Protein elongation factor 2 as a target for antifungal and antiparasitic agents
US5965612A (en) * 1997-08-22 1999-10-12 Merck & Co., Inc. 4-cyano-4-deformylsordaricin derivatives
JP4339505B2 (ja) * 1997-08-22 2009-10-07 メルク エンド カムパニー インコーポレーテッド ４−シアノ−４−デホルミルソルダリン誘導体
US5972996A (en) * 1997-08-22 1999-10-26 Merck & Co., Inc. 4-cyano-4-deformylsordarin derivatives
US6136853A (en) * 1997-10-03 2000-10-24 Merck & Co., Inc. Sordarin derivatives
FI974385A0 (fi) 1997-12-01 1997-12-01 Xyrofin Oy Anvaendning av xylitol foer bekaempning av jaestinfektion och xylitolpreparat foer denna anvaendning
US7070965B1 (en) * 1998-04-14 2006-07-04 Zhenhua Yang Small molecule anticancer compounds and related production process
MA26628A1 (fr) * 1998-05-11 2004-12-20 Glaxo Wellcome Sa Morpholino ethers
DE69913369T2 (de) 1998-10-26 2004-10-14 Merck & Co., Inc. Mikrobielle transformationsprodukte
EP1191948A2 (en) 1999-06-11 2002-04-03 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
EP1228049A1 (en) 1999-11-11 2002-08-07 Glaxo Wellcome S.A. Antifungal sordaricin derivatives
AU2001289063A1 (en) * 2000-09-15 2002-03-26 Bristol-Myers Squibb Company Novel thio derivatives of sordarin as antifungal agents
EP1390081A2 (en) * 2001-01-08 2004-02-25 Neorx Corporation Therapeutic and diagnostic compounds, compositions, and methods
WO2003007878A2 (en) 2001-07-18 2003-01-30 Merck & Co., Inc. Antifungal agents of sordarin derivatives
US7045116B2 (en) 2001-12-13 2006-05-16 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
CA2469879A1 (en) * 2001-12-14 2003-06-26 Merck & Co. Inc. A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent
MXPA05007156A (es) * 2002-12-31 2005-09-21 Nektar Therapeutics Formulacion farmaceuticas aerosolizable para terapia para infecciones fungicas.
US9314524B2 (en) 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
US8419948B2 (en) * 2009-11-22 2013-04-16 United Laboratories International, Llc Wastewater treatment
WO2012033427A1 (ru) * 2010-09-08 2012-03-15 Dalin Mikhail Viktorovich Способ лечения микотических инфекций и препарат для его осуществления
RU2630403C2 (ru) * 2016-02-25 2017-09-07 Жанна Владимировна Вараткова Абразивная масса для изготовления инструмента с высокими номерами структуры

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH465771A (de) * 1965-12-06 1968-11-30 Sandoz Ag Verfahren zur Herstellung eines neuen Antibioticums
JPH0615555B2 (ja) * 1985-08-14 1994-03-02 三共株式会社 抗生物質ゾフイマリン
JP3189443B2 (ja) * 1992-11-20 2001-07-16 萬有製薬株式会社 抗真菌性物質ｂｅ−３１４０５
CZ88499A3 (cs) * 1996-09-12 1999-10-13 Merck And Co., Inc. Kombinace látek s antifungálním účinkem

Also Published As

Publication number Publication date
ES2137549T3 (es) 1999-12-16
DE69512041T2 (de) 2000-02-03
ZA959362B (en) 1996-05-08
BG100699A (bg) 1997-02-28
NZ296091A (en) 1998-06-26
AU3980995A (en) 1996-05-31
IL115905A0 (en) 1996-01-31
CZ202796A3 (en) 1997-02-12
CO4520226A1 (es) 1997-10-15
AR013815A1 (es) 2001-01-31
NO962856L (no) 1996-09-05
OA10303A (en) 1997-10-07
JPH09508144A (ja) 1997-08-19
AP614A (en) 1997-09-05
SI0753001T1 (en) 1999-12-31
EP0753001B1 (en) 1999-09-08
PE49696A1 (es) 1996-12-05
DK0753001T3 (da) 2000-05-08
TW321644B (fi) 1997-12-01
NO962856D0 (no) 1996-07-05
AU704405B2 (en) 1999-04-22
HUT76292A (en) 1997-07-28
EP0753001A1 (en) 1997-01-15
BR9506473A (pt) 1997-10-07
AP9600824A0 (en) 1996-07-31
CN1143965A (zh) 1997-02-26
KR100391401B1 (ko) 2003-12-31
CN1056849C (zh) 2000-09-27
HU218611B (hu) 2000-10-28
FI962773A (fi) 1996-08-26
MX9602563A (es) 1997-05-31
EE9600117A (et) 1997-04-15
FI962773A0 (fi) 1996-07-05
HU9601865D0 (en) 1996-11-28
US5854280A (en) 1998-12-29
US5952334A (en) 1999-09-14
ATE184284T1 (de) 1999-09-15
NO307092B1 (no) 2000-02-07
HK1004222A1 (en) 1998-11-20
CA2179403A1 (en) 1996-05-17
RU2152398C1 (ru) 2000-07-10
IS4352A (is) 1996-06-10
GR3031677T3 (en) 2000-02-29
WO1996014326A1 (en) 1996-05-17
DE69512041D1 (de) 1999-10-14
SK88496A3 (en) 1997-04-09

Similar Documents

Publication Publication Date Title
BG62620B1 (en) Carbocyclic compounds
EP0423714A3 (en) Hair revitalizing agent
TW288011B (fi)
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
CA2009735A1 (en) Insecticidally active nitro compounds
GB9514473D0 (en) Chemical compounds
CA2132098A1 (en) Antimicrobial imidazoles for regulating the greasiness of the skin
CS960586A2 (en) Insekticidni a akaricidni prostredek a zpusob vyroby ucinnych latek
MX9602806A (es) Derivados del 1,2,4-oxadiazol y su uso como parasiticidas para animales.
EP0322779A3 (en) Benzolactam compounds and pharmaceutical uses thereof
FI942313A (fi) Välituote atsitromysiiniä varten
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
CA2138289A1 (en) N-substituted azabicycloheptane derivatives, the preparation and use thereof
EP0411733A3 (en) 11-beta-aryle-gona-4,9-dien-3-ones
NZ325235A (en) New phenylamidine derivatives, a process for preparing the same and their use as medicaments
MY132057A (en) Quinoxalinones, a process for their preparation and their use
ZA87773B (en) 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
FI871752A (fi) Triatsoli- ja tetrahydrofuraaniryhmän sisältävät yhdisteet, niiden käyttäminen fungisideina ja niiden valmistusmenetelmät sekä välituotteet
PL321757A1 (en) Fungicidal azaheterocycloalkenes
IT1254199B (it) Tiazolilpirroli ad attivita' fungicida
TW239124B (en) Process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
EP0877618A4 (fi)
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
MX9500251A (es) Derivado de indano, procedimiento para prepararlo.
EP0757048A4 (en) ETHER COMPOUND AND ITS USE